<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36609402</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>06</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Molecular subtypes of ALS are associated with differences in patient prognosis.</ArticleTitle><Pagination><StartPage>95</StartPage><MedlinePgn>95</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">95</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-35494-w</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease with poorly understood clinical heterogeneity, underscored by significant differences in patient age at onset, symptom progression, therapeutic response, disease duration, and comorbidity presentation. We perform a patient stratification analysis to better understand the variability in ALS pathology, utilizing postmortem frontal and motor cortex transcriptomes derived from 208 patients. Building on the emerging role of transposable element (TE) expression in ALS, we consider locus-specific TEs as distinct molecular features during stratification. Here, we identify three unique molecular subtypes in this ALS cohort, with significant differences in patient survival. These results suggest independent disease mechanisms drive some of the clinical heterogeneity in ALS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eshima</LastName><ForeName>Jarrett</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1111-9069</Identifier><AffiliationInfo><Affiliation>School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85287, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Samantha A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-8202-2435</Identifier><AffiliationInfo><Affiliation>School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85287, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marschall</LastName><ForeName>Ethan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85287, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>NYGC ALS Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Bowser</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5404-7259</Identifier><AffiliationInfo><Affiliation>Departments of Translational Neuroscience and Neurology, Barrow Neurological Institute, Phoenix, AZ, 85013, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>St. Joseph's Hospital and Medical Center, Department of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plaisier</LastName><ForeName>Christopher L</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0003-3273-5717</Identifier><AffiliationInfo><Affiliation>School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85287, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Barbara S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>School of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, 85287, USA. BarbaraSmith@asu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073537" MajorTopicYN="N">Biological Variation, Population</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>R.B. is the chairman of the board of Iron Horse Diagnostics, which has not contributed financially, or by any other means, to this study. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>7</Day><Hour>16</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36609402</ArticleId><ArticleId IdType="pmc">PMC9822908</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-35494-w</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-35494-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mitchell JD, et al. Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)&#x2013;a 20-year review: can we do better? Amyotroph. Lateral Scler. 2010;11:537&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">20565332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowser R, Turner MR, Shefner J. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat. Rev. Neurol. 2011;7:631&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">21989244</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, et al. Factors predicting survival in ALS: a multicenter Italian study. J. Neurol. 2017;264:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27778156</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout, R., Verstraete, E., Van Den Heuvel, M. P., Veldink, J. H. &amp; Van Den Berg, L.H. Patterns of symptom development in patients with motor neuron disease. Amyotroph. Lateral Scler. Frontotemporal Degener.19, 21&#x2013;28 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29037065</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell JL, et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer&#x2019;s disease: a case-control study. Lancet Neurol. 2012;11:868&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3490201</ArticleId><ArticleId IdType="pubmed">22951070</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, et al. Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 2019;29:1164&#x2013;1177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronica E, et al. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex. Neurobiol. Dis. 2015;74:359&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">25500340</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G, et al. Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS. Sci. Rep. 2019;9:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6620285</ArticleId><ArticleId IdType="pubmed">31292500</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Investig. 2020;130:e139741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WR, Ardeljan D, Pacyna CN, Payer LM, Burns KH. SQuIRE reveals locus-specific regulation of interspersed repeat expression. Nucleic acids Res. 2019;47:e27&#x2013;e27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6411935</ArticleId><ArticleId IdType="pubmed">30624635</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual-Montano A, Carazo JM, Kochi K, Lehmann D, Pascual-Marqui RD. Nonsmooth nonnegative matrix factorization (nsNMF) IEEE Trans. Pattern Anal. Mach. Intell. 2006;28:403&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">16526426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic acids Res. 2016;44:W90&#x2013;W97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA. 2005;102:15545&#x2013;15550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell. 2017;169:1276&#x2013;1290.</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498&#x2013;2504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma. 2008;9:1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldham MC, et al. Functional organization of the transcriptome in human brain. Nat. Neurosci. 2008;11:1271&#x2013;1282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2756411</ArticleId><ArticleId IdType="pubmed">18849986</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Mellor J, Wu J, DeLisi C. VisANT: an online visualization and analysis tool for biological interaction data. BMC Bioinforma. 2004;5:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC368431</ArticleId><ArticleId IdType="pubmed">15028117</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel AP, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344:1396&#x2013;1401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4123637</ArticleId><ArticleId IdType="pubmed">24925914</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F, et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 2011;12:2825&#x2013;2830.</Citation></Reference><Reference><Citation>O&#x2019;Connor SA, et al. Neural G0: a quiescent-like state found in neuroepithelial-derived cells and glioma. Mol. Syst. Biol. 2021;17:e9522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186478</ArticleId><ArticleId IdType="pubmed">34101353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958;53:457&#x2013;481.</Citation></Reference><Reference><Citation>Flynn G, Maru S, Loughlin J, Romero IA, Male D. Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 2003;136:84&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">12620646</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto T, et al. CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model. Neurosci. Lett. 2012;520:115&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">22634473</ArticleId></ArticleIdList></Reference><Reference><Citation>Boche D, Perry VH, Nicoll JA. Activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol. 2013;39:3&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">23252647</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo C, et al. CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients. Mol. Cell. Neurosci. 2017;85:162&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">28989002</ArticleId></ArticleIdList></Reference><Reference><Citation>Doens D, Fern&#xe1;ndez PL. Microglia receptors and their implications in the response to amyloid &#x3b2; for Alzheimer&#x2019;s disease pathogenesis. J. Neuroinflammation. 2014;11:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3975152</ArticleId><ArticleId IdType="pubmed">24625061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona AE, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006;9:917&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">16732273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes GM, Woodroofe MN, Cuzner ML. Microglia are the major cell type expressing MHC class II in human white matter. J. Neurological Sci. 1987;80:25&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">3302117</ArticleId></ArticleIdList></Reference><Reference><Citation>El KH, et al. Scavenger receptor-mediated adhesion of microglia to &#x3b2;-amyloid fibrils. Nature. 1996;382:716&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pubmed">8751442</ArticleId></ArticleIdList></Reference><Reference><Citation>Butchi NB, Du M, Peterson KE. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia. 2010;58:650&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3767435</ArticleId><ArticleId IdType="pubmed">19998480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahoy JD, et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 2008;28:264&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671143</ArticleId><ArticleId IdType="pubmed">18171944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer&#x2019;s disease. Cell. 2013;153:707&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677161</ArticleId><ArticleId IdType="pubmed">23622250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadge GD, et al. Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proc. Natl Acad. Sci. 2003;100:9554&#x2013;9559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC170956</ArticleId><ArticleId IdType="pubmed">12876198</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuhrmann M, et al. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer&#x2019;s disease. Nat. Neurosci. 2010;13:411&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4072212</ArticleId><ArticleId IdType="pubmed">20305648</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, McGeer EG. Glial reactions in Parkinson&#x2019;s disease. Mov. Disord.: Off. J. Mov. Disord. Soc. 2008;23:474&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">18044695</ArticleId></ArticleIdList></Reference><Reference><Citation>Klegeris A, McGeer PL. Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol. aging. 2002;23:787&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pubmed">12392782</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, C., Cui, G., Zhu, M., Kang, X. &amp; Guo, H. Neuroinflammation in Alzheimer&#x2019;s disease: chemokines produced by astrocytes and chemokine receptors. International journal of clinical and experimental pathology 7, 8342 NA.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4314046</ArticleId><ArticleId IdType="pubmed">25674199</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol. 2002;23:541&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">12401407</ArticleId></ArticleIdList></Reference><Reference><Citation>Bido S, et al. Microglia-specific overexpression of &#x3b1;-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat. Commun. 2021;12:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556263</ArticleId><ArticleId IdType="pubmed">34716339</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Haynes RL, Sidman RL, Vartanian T. TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle. 2007;6:2859&#x2013;2868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4316738</ArticleId><ArticleId IdType="pubmed">18000403</ArticleId></ArticleIdList></Reference><Reference><Citation>Mc GU, Beyaert R, van LO. Death receptor signalling in central nervous system inflammation and demyelination. Trends Neurosci. 2011;34:619&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">21999927</ArticleId></ArticleIdList></Reference><Reference><Citation>Heras-Sandoval D, P&#xe9;rez-Rojas JM, Hern&#xe1;ndez-Dami&#xe1;n J, Pedraza-Chaverri J. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell. Signal. 2014;26:2694&#x2013;2701.</Citation><ArticleIdList><ArticleId IdType="pubmed">25173700</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 2005;201:647&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213053</ArticleId><ArticleId IdType="pubmed">15728241</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson DS, Oliver PL. ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants. 2020;9:743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7463655</ArticleId><ArticleId IdType="pubmed">32823544</ArticleId></ArticleIdList></Reference><Reference><Citation>Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arteriosclerosis, thrombosis, Vasc. Biol. 1999;19:472&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">10073946</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib N, et al. Disease-associated astrocytes in Alzheimer&#x2019;s disease and aging. Nat. Neurosci. 2020;23:701&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262034</ArticleId><ArticleId IdType="pubmed">32341542</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsalve DM, et al. Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression. Cell Death Dis. 2013;4:e513&#x2013;e513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3734818</ArticleId><ArticleId IdType="pubmed">23449449</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata H, et al. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic acids Res. 1999;27:29&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC148090</ArticleId><ArticleId IdType="pubmed">9847135</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliver PL, et al. Oxr1 is essential for protection against oxidative stress-induced neurodegeneration. PLoS Genet. 2011;7:e1002338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3197693</ArticleId><ArticleId IdType="pubmed">22028674</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler DA, et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 1996;738:265&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">8955522</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu WN, et al. Mitochondrial NDUFA4L2 attenuates the apoptosis of nucleus pulposus cells induced by oxidative stress via the inhibition of mitophagy. Exp. Mol. Med. 2019;51:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6861227</ArticleId><ArticleId IdType="pubmed">31740659</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews ZB, Diano S, Horvath TL. Mitochondrial uncoupling proteins in the CNS: in support of function and survival. Nat. Rev. Neurosci. 2005;6:829&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">16224498</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002;277:29626&#x2013;29633.</Citation><ArticleIdList><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M, et al. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy. 2014;10:1256&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4203551</ArticleId><ArticleId IdType="pubmed">24905722</ArticleId></ArticleIdList></Reference><Reference><Citation>Artenstein AW, Opal SM. Proprotein convertases in health and disease. N. Engl. J. Med. 2011;365:2507&#x2013;2518.</Citation><ArticleIdList><ArticleId IdType="pubmed">22204726</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbro S, Seeds NW. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. J. Neurochemistry. 2009;109:303&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">19222708</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiltunen M, et al. Ubiquilin 1 modulates amyloid precursor protein trafficking and A&#x3b2; secretion. J. Biol. Chem. 2006;281:32240&#x2013;32253.</Citation><ArticleIdList><ArticleId IdType="pubmed">16945923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R, et al. UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome. Cell. 2016;166:935&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwase K, et al. Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment. J. Biol. Chem. 2000;275:11929&#x2013;11933.</Citation><ArticleIdList><ArticleId IdType="pubmed">10766821</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat. Neurosci. 2016;19:771&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5745011</ArticleId><ArticleId IdType="pubmed">27227366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Kisler K, Montagne A, Toga AW, Zlokovic BV. The role of brain vasculature in neurodegenerative disorders. Nat. Neurosci. 2018;21:1318&#x2013;1331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6198802</ArticleId><ArticleId IdType="pubmed">30250261</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins MA, An J, Hood BL, Conrads TP, Bowser RP. Label-Free LC&#x2013;MS/MS proteomic analysis of cerebrospinal fluid identifies Protein/Pathway alterations and candidate biomarkers for amyotrophic lateral sclerosis. J. Proteome Res. 2015;14:4486&#x2013;4501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5592736</ArticleId><ArticleId IdType="pubmed">26401960</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksenov MY, et al. The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer&#x2019;s disease. Neurochem. Res. 1999;24:767&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pubmed">10447460</ArticleId></ArticleIdList></Reference><Reference><Citation>Adav SS, Park JE, Sze SK. Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer&#x2019;s disease. Mol. brain. 2019;12:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350377</ArticleId><ArticleId IdType="pubmed">30691479</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro JF, et al. Spatial Transcriptomics Reveals Genes Associated with Dysregulated Mitochondrial Functions and Stress Signaling in Alzheimer Disease. Iscience. 2020;23:101556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522123</ArticleId><ArticleId IdType="pubmed">33083725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan MG, et al. Genome wide profiling of altered gene expression in the neocortex of Alzheimer&#x2019;s disease. J. Neurosci. Res. 2010;88:1157&#x2013;1169.</Citation><ArticleIdList><ArticleId IdType="pubmed">19937809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhabra R, Dubey R, Saini N. Cooperative and individualistic functions of the microRNAs in the miR-23a~ 27a~ 24-2 cluster and its implication in human diseases. Mol. cancer. 2010;9:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2940846</ArticleId><ArticleId IdType="pubmed">20815877</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, et al. miR-219 cooperates with miR-338 in myelination and promotes myelin repair in the CNS. Developmental Cell. 2017;40:566&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5569304</ArticleId><ArticleId IdType="pubmed">28350989</ArticleId></ArticleIdList></Reference><Reference><Citation>Santa-Maria I, et al. Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J. Clin. Investig. 2015;125:681&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4319412</ArticleId><ArticleId IdType="pubmed">25574843</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann SM, et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 2012;15:827&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pubmed">22610069</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaub M, Keller W. RNA editing by adenosine deaminases generates RNA and protein diversity. Biochimie. 2002;84:791&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">12457566</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A, et al. p63, a p53 homolog at 3q27&#x2013;29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell. 1998;2:305&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">9774969</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 2015;12:453&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4739640</ArticleId><ArticleId IdType="pubmed">25822800</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowakowski TJ, et al. Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex. Science. 2017;358:1318&#x2013;1323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991609</ArticleId><ArticleId IdType="pubmed">29217575</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, et al. Wild-type microglia extend survival in PU. 1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA. 2006;103:16021&#x2013;16026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey, J. et al. Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nature Neuroscience, 1&#x2013;13 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36482247</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson AG, et al. CSF chitinase proteins in amyotrophic lateral sclerosis. J. Neurol., Neurosurg. Psychiatry. 2019;90:1215&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pubmed">31123140</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, et al. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression. J. Neurol., Neurosurg. Psychiatry. 2018;89:239&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">29142138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ill&#xe1;n-Gala I, et al. CSF sAPP&#xdf;, YKL-40, and NfL along the ALS-FTD spectrum. Neurology. 2018;91:e1619&#x2013;e1628.</Citation><ArticleIdList><ArticleId IdType="pubmed">30291183</ArticleId></ArticleIdList></Reference><Reference><Citation>Gille B, et al. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? J. Neurol., Neurosurg. Psychiatry. 2019;90:1338&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pubmed">31175169</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu L, et al. Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes. J. Neurol., Neurosurg. Psychiatry. 2020;91:350&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147184</ArticleId><ArticleId IdType="pubmed">31937582</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, et al. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J. Neuropathol. Exp. Neurol. 2004;63:964&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pubmed">15453095</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J. Neurol., Neurosurg. Psychiatry. 2013;84:1161&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786661</ArticleId><ArticleId IdType="pubmed">23264687</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S, et al. Distribution of GABAA receptor mRNA in the motor cortex of ALS patients. J. Neuropathol. Exp. Neurol. 2003;62:1041&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pubmed">14575239</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S, et al. GABAA-receptor mRNA expression in the prefrontal and temporal cortex of ALS patients. J. Neurological Sci. 2006;250:124&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">17011586</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Wen S, Bowser R, Appel SH. Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology. 2009;72:1614&#x2013;1616.</Citation><ArticleIdList><ArticleId IdType="pubmed">19414730</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, et al. Impaired blood&#x2013;brain/spinal cord barrier in ALS patients. Brain Res. 2012;1469:114&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">22750125</ArticleId></ArticleIdList></Reference><Reference><Citation>Saul J, et al. Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis. Acta Neuropathologica Commun. 2020;8:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318439</ArticleId><ArticleId IdType="pubmed">32586411</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, et al. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J. Clin. Investig. 2011;121:726&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3026736</ArticleId><ArticleId IdType="pubmed">21206091</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EY, et al. Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons. Cell Rep. 2019;27:1409&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6508629</ArticleId><ArticleId IdType="pubmed">31042469</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 2019;22:167&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AL, et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603:131&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, et al. TDP-43 represses cryptic exon inclusion in the FTD&#x2013;ALS gene UNC13A. Nature. 2022;603:124&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed ZE, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 2019;22:180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavasoli M, et al. Mechanism of action and therapeutic route for a muscular dystrophy caused by a genetic defect in lipid metabolism. Nat. Commun. 2022;13:1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943011</ArticleId><ArticleId IdType="pubmed">35322809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ. The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) J. neurological Sci. 2010;288:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">19840884</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>A. F. A. Smit, R. Hubley, P. Green, RepeatMasker Open-4.0. 2013&#x2013;2015. (2015).</Citation></Reference><Reference><Citation>Bao W, Kojima KK, Kohany O. Repbase Update, a database of repetitive elements in eukaryotic genomes. Mob. DNA. 2015;6:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4455052</ArticleId><ArticleId IdType="pubmed">26045719</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 2011;12:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3163565</ArticleId><ArticleId IdType="pubmed">21816040</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DD, Seung HS. Learning the parts of objects by non-negative matrix factorization. Nature. 1999;401:788&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pubmed">10548103</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaujoux R, Seoighe C. A flexible R package for nonnegative matrix factorization. BMC Bioinforma. 2010;11:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2912887</ArticleId><ArticleId IdType="pubmed">20598126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho YJ, et al. Single-cell RNA-seq analysis identifies markers of resistance to targeted BRAF inhibitors in melanoma cell populations. Genome Res. 2018;28:1353&#x2013;1363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120620</ArticleId><ArticleId IdType="pubmed">30061114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Park H. Sparse non-negative matrix factorizations via alternating non-negativity-constrained least squares for microarray data analysis. Bioinformatics. 2007;23:1495&#x2013;1502.</Citation><ArticleIdList><ArticleId IdType="pubmed">17483501</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassal B, et al. The reactome pathway knowledgebase. Nucleic acids Res. 2020;48:D498&#x2013;D503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145712</ArticleId><ArticleId IdType="pubmed">31691815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Blalock EM, et al. Incipient Alzheimer&#x2019;s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl Acad. Sci. USA. 2004;101:2173&#x2013;2178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC357071</ArticleId><ArticleId IdType="pubmed">14769913</ArticleId></ArticleIdList></Reference><Reference><Citation>Therneau TM, Lumley T. Package &#x2018;survival&#x2019;. R. Top. Doc. 2015;128:28&#x2013;33.</Citation></Reference><Reference><Citation>Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 2015;33:495&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4430369</ArticleId><ArticleId IdType="pubmed">25867923</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshima, J. et al. Molecular subtypes of ALS are associated with differences in patient prognosis. BSmithLab/ALSPatientStratification: v1.0.0, zenodo 10.5281/zenodo.7296869 (2022).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>